Acino snaps up portfolio of products from Takeda

16 October 2019 - Deborah Wilkes


Switzerland’s Acino is acquiring a portfolio of OTC and prescription pharmaceuticals from Japan’s Takeda in a deal worth more than USD200 million.

Click tags below for more information on topics:

Acino Takeda

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: